These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36151300)

  • 1. Variation of volatile organic compound levels within ambient room air and its impact upon the standardisation of breath sampling.
    Hewitt MJ; Belluomo I; Zuffa S; Boshier PR; Myridakis A
    Sci Rep; 2022 Sep; 12(1):15887. PubMed ID: 36151300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
    Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
    J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of an extended human volatome with comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry.
    Phillips M; Cataneo RN; Chaturvedi A; Kaplan PD; Libardoni M; Mundada M; Patel U; Zhang X
    PLoS One; 2013; 8(9):e75274. PubMed ID: 24086492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The peppermint breath test: a benchmarking protocol for breath sampling and analysis using GC-MS.
    Wilkinson M; White I; Hamshere K; Holz O; Schuchardt S; Bellagambi FG; Lomonaco T; Biagini D; Di FF; Fowler SJ
    J Breath Res; 2021 Jan; 15(2):. PubMed ID: 33302258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods to Detect Volatile Organic Compounds for Breath Biopsy Using Solid-Phase Microextraction and Gas Chromatography-Mass Spectrometry.
    Schulz E; Woollam M; Grocki P; Davis MD; Agarwal M
    Molecules; 2023 Jun; 28(11):. PubMed ID: 37299010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The variability of volatile organic compounds in the indoor air of clinical environments.
    Salman D; Ibrahim W; Kanabar A; Joyce A; Zhao B; Singapuri A; Wilde M; Cordell RL; McNally T; Ruszkiewicz D; Hadjithekli A; Free R; Greening N; Gaillard EA; Beardsmore C; Monks P; Brightling C; Siddiqui S; Thomas CLP
    J Breath Res; 2021 Dec; 16(1):. PubMed ID: 34724656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic insights at the finish line: deciphering physiological changes in ultramarathon runners through breath VOC analysis.
    Chou H; Arthur K; Shaw E; Schaber C; Boyle B; Allsworth M; Kelley EF; Stewart GM; Wheatley CM; Schwartz J; Fermoyle CC; Ziegler BL; Johnson KA; Robach P; Basset P; Johnson BD
    J Breath Res; 2024 Feb; 18(2):. PubMed ID: 38290132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of real-time and hyphenated mass spectrometry for improved characterisation of exhaled breath biomarkers in clinical research.
    Lamy E; Roquencourt C; Zhou B; Salvator H; Moine P; Annane D; Devillier P; Bardin E; Grassin-Delyle S
    Anal Bioanal Chem; 2024 Sep; 416(22):4929-4939. PubMed ID: 38980330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive breath collection in murine models using a newly developed sampling device
    Hintzen KFH; Smolinska A; Mommers AGR; Bouvy ND; van Schooten FJ; Lubbers T
    J Breath Res; 2022 Feb; 16(2):. PubMed ID: 35086080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying robust and reliable volatile organic compounds in human sebum for biomarker discovery.
    Zhang JD; Le MN; Hill KJ; Cooper AA; Stuetz RM; Donald WA
    Anal Chim Acta; 2022 Nov; 1233():340506. PubMed ID: 36283785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multiple-method comparative study using GC-MS, AMDIS and in-house-built software for the detection and identification of "unknown" volatile organic compounds in breath.
    Marder D; Tzanani N; Baratz A; Drug E; Prihed H; Weiss S; Ben-Chetrit E; Eichel R; Dagan S; Yishai Aviram L
    J Mass Spectrom; 2021 Oct; 56(10):e4782. PubMed ID: 34523187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
    Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E
    Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of high relative humidity and dry purging on VOCs obtained during breath sampling on common sorbent tubes.
    Wilkinson M; White IR; Goodacre R; Nijsen T; Fowler SJ
    J Breath Res; 2020 Jul; 14(4):046006. PubMed ID: 32153262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimisation of sampling parameters for standardised exhaled breath sampling.
    Doran SLF; Romano A; Hanna GB
    J Breath Res; 2017 Dec; 12(1):016007. PubMed ID: 29211685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of thermal desorption-gas chromatography-mass spectrometry (TD-GC-MS) on identification of odorant emission focus by volatile organic compounds characterisation.
    Rodríguez-Navas C; Forteza R; Cerdà V
    Chemosphere; 2012 Nov; 89(11):1426-36. PubMed ID: 22776256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory symptoms and peak expiratory flow in children with asthma in relation to volatile organic compounds in exhaled breath and ambient air.
    Delfino RJ; Gong H; Linn WS; Hu Y; Pellizzari ED
    J Expo Anal Environ Epidemiol; 2003 Sep; 13(5):348-63. PubMed ID: 12973363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross Platform Analysis of Volatile Organic Compounds Using Selected Ion Flow Tube and Proton-Transfer-Reaction Mass Spectrometry.
    Lin GP; Vadhwana B; Belluomo I; Boshier PR; Španěl P; Hanna GB
    J Am Soc Mass Spectrom; 2021 May; 32(5):1215-1223. PubMed ID: 33831301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of air quality in indoor and outdoor environments: Impact of anti-COVID-19 measures.
    Ninyà N; Vallecillos L; Marcé RM; Borrull F
    Sci Total Environ; 2022 Aug; 836():155611. PubMed ID: 35504390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
    Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
    J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis.
    Dallinga JW; Smolinska A; van Schooten FJ
    Methods Mol Biol; 2014; 1198():251-63. PubMed ID: 25270934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.